The role of serum vitamin D in patients with normal ovarian reserve undergoing the first IVF/ICSI cycle

被引:1
|
作者
Luo, Rong [1 ]
Wang, Jiahui [2 ]
Yang, Yu [1 ]
Xu, Cen [1 ]
Yang, Minyan [1 ]
Zhu, Dandan [1 ]
Wang, Jia [1 ]
Zhang, Ping [1 ]
Ge, Hongshan [1 ]
机构
[1] Nanjing Med Univ, Dept Reprod Med, Affiliated Taizhou Peoples Hosp, Taizhou, Peoples R China
[2] Southeast Univ, Sch Med, Nanjing, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
vitamin D; IVF; pregnancy; embryo transfer; assisted reproduction; VITRO FERTILIZATION OUTCOMES; INFERTILE WOMEN; BLASTOCYST; FERTILITY;
D O I
10.3389/fendo.2023.1249445
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The debate over the impact of vitamin D in assisted reproduction continues. The purpose of our study was to assess embryo quality and pregnancy outcomes among groups with different levels of vitamin D after the first in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycle in patients with normal ovarian reserve (NOR).Methods Patients in this retrospective cohort study were divided into three groups: severe vitamin D deficiency group (25OH-D < 10 ng/ml), vitamin D deficiency group (10 ng/ml =25OH-D < 20 ng/ml), and non-vitamin D deficiency group (25OH-D = 20 ng/ml). The primary outcome was clinical pregnancy, while the secondary outcomes were mature oocytes, oocyte fertilization, available cleavage embryos, available blastocysts, biochemical pregnancy, early abortion, and embryo implantation. A modified Poisson regression model and multiple linear regression analysis were conducted for the multivariate analysis.Results 264 NOR patients undergoing the first IVF/ICSI cycles were included. For the primary outcome, there was no significant difference in clinical pregnancy between the severe vitamin D deficiency group and the other two groups (vitamin D deficiency group: adjusted RR = 1.026; 0.780 - 1.350; P = 0.854; non-vitamin D deficiency group: adjusted RR = 1.092; 0.743 - 1.605; P = 0.652). For all secondary outcomes, no significant differences were observed among the severe vitamin D deficiency, vitamin D deficiency, and non-vitamin D deficiency groups (P > 0.05). Exploratory subgroup analyses concerning the season of embryo transfer, phase of embryo transferred, and endometrial thickness, as well as the sensitivity analysis using logistic regression models for the primary outcome, revealed comparable clinical pregnancy rates among the groups (P > 0.05). Subgroup analysis concerning ovarian stimulation protocol indicated that in the subgroup of gonadotrophin-releasing hormone (GnRH) antagonist protocol, the clinical pregnancy rate of the non-vitamin D deficiency group was significantly higher than that of the other two groups (P < 0.05).Conclusion Serum vitamin D level was not associated with embryo quality and pregnancy outcomes for patients with NOR. Further studies with greater sample sizes and a longer follow-up period are needed to elucidate the relationships between vitamin D levels and IVF outcomes.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET
    Lanlan Fang
    Yiping Yu
    Ruizhe Zhang
    Jingyan He
    Ying-Pu Sun
    Scientific Reports, 6
  • [32] ROLE OF PERIFOLLICULAR DOPPLER BLOOD FLOW IN PREDICTING CYCLE RESPONSE IN NORMORESPONDERS UNDERGOING IVF/ICSI.
    Malhotra, N.
    Bahadur, A.
    Singh, N.
    Mittal, S.
    FERTILITY AND STERILITY, 2012, 98 (03) : S274 - S274
  • [33] Individualised gonadotropin dose selection usingmarkers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperminjection (IVF/ICSI)
    Lensen, Sarah F.
    Wilkinson, Jack
    Leijdekkers, Jori A.
    La Marca, Antonio
    Mol, Ben Willem J.
    Marjoribanks, Jane
    Torrance, Helen
    Broekmans, Frank J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (02):
  • [34] The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, Xiuxian
    Ye, Hongjuan
    Fu, Yonglun
    MEDICINE, 2016, 95 (28)
  • [35] Natural Cycle IVF can be a successful treatment alternative for patients with low ovarian reserve
    Nitzschke, Markus
    Stetson, Sonny J.
    Ruyalcaba, Luis A.
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2013, 17 (05): : 310 - 312
  • [36] Impact of serum vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in egg donors
    Iglesias, C.
    Fabris, A.
    Pacheco, A.
    Cruz, M.
    Patel, A.
    Patel, J.
    Fatemi, H.
    Garcia-Velasco, J. A.
    HUMAN REPRODUCTION, 2016, 31 : 88 - 88
  • [37] Efficiency of DHEA on diminished ovarian reserve patients undergoing IVF-ET based on ultrasonography
    Yuan, Hua
    Ou, Qizhi
    Ma, Yan
    Chen, Rong
    Wu, Huimei
    Li, Feiwen
    Hang, Fu
    Jin, Yufu
    Li, Mujun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 14337 - 14344
  • [38] Ovarian reserve screening with Clomiphene Citrate Challenge test in patients undergoing IVF: impact of age
    Anserini, P
    Remorgida, V
    Gaggero, G
    Magnasco, A
    Capitanio, GL
    HUMAN OOCYTES: FROM PHYSIOLOGY TO IVF, 1997, : 133 - 137
  • [39] Analysis of the split insemination (IVF plus ICSI) treatment in patients with borderline semen in first cycle
    Yu, Chun-Mei
    Fei-Liu, Jing-Hua
    Zhang, Jing-Hua
    Dai, Xiu-Liang
    Wang, Yu-Feng
    Chen, Li
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (10)
  • [40] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    HUMAN REPRODUCTION, 2016, 31 : 420 - 421